Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients. (Q42837781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mercè Brunet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

David Guillén

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Federico Cofán

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Olga Millán

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Montse Cofán

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

357-366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

Statins in endothelial signaling and activation

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Statins and the vascular endothelial inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Toward immunomodulatory and anti-inflammatory properties of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: statins as immunomodulatory agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Statins as immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Minimization of immunosuppression: transplant immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Kidney transplantation: the ideal immunosuppression regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Calcineurin inhibitor minimization protocols in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Minimization of steroids in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Determination of atorvastatin and its metabolite ortho-hydroxyatorvastatin in human plasma by on-line anion-exchange solid-phase extraction and liquid chromatography tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

The effects of lipid-lowering agents on acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Is the intracellular ATP concentration of CD4+ T-Cells a predictive biomarker of immune status in stable transplant recipients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256393

HMG CoA reductase inhibitors (statins) for kidney transplant recipients

21 January 2018

1 reference

12 December 2020

Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay

1 reference

12 December 2020

Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatin

1 reference

12 December 2020

Inflammatory lipids as a target for therapy in the rheumatic diseases

1 reference

12 December 2020

Effect of itraconazole on the pharmacokinetics of atorvastatin

1 reference

12 December 2020

Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood.

1 reference

12 December 2020

Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry

1 reference

12 December 2020

Comparison of the effects of simvastatin and pravastatin on acute rejection episodes in renal transplant patients

1 reference

12 December 2020

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

1 reference

12 December 2020

Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction

1 reference

12 December 2020

T-cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy

1 reference

12 December 2020

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

1 reference

12 December 2020

Effects of simvastatin on human T cells in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21047146%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference